| |
Last Name |
First Name |
Research/Clinical Interest Title |
Keywords |
 |
TIWARI |
HEMANT |
Genetic association/linkage analysis |
Obesity, SLE, RA, Epilepsy |
 |
TIWARI |
HEMANT |
Genetic association/linkage analysis |
Obesity, SLE, RA, Epilepsy |
 |
TIWARI |
HEMANT |
Genetic association/linkage analysis |
Obesity, SLE, RA, Epilepsy |
 |
TIWARI |
HEMANT |
Genetic association/linkage analysis |
Obesity, SLE, RA, Epilepsy |
 |
TIWARI |
HEMANT |
Genetic association/linkage analysis |
Obesity, SLE, RA, Epilepsy |
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TOWNES |
TIM |
Developmental Regulation of Gene Expression |
|
 |
TURNBOUGH |
CHARLES |
Structure/Function of the Bacillus anthracis Exosporium; Bacterial Gene Regulation |
anthrax, Bacillus anthracis, exosporium, E. coli, gene regulation. reiterative transcription, transcription start site switching |
 |
TURNBOUGH |
CHARLES |
Structure/Function of the Bacillus anthracis Exosporium; Bacterial Gene Regulation |
anthrax, Bacillus anthracis, exosporium, E. coli, gene regulation. reiterative transcription, transcription start site switching |
 |
TURNBOUGH |
CHARLES |
Structure/Function of the Bacillus anthracis Exosporium; Bacterial Gene Regulation |
anthrax, Bacillus anthracis, exosporium, E. coli, gene regulation. reiterative transcription, transcription start site switching |
 |
TURNBOUGH |
CHARLES |
Structure/Function of the Bacillus anthracis Exosporium; Bacterial Gene Regulation |
anthrax, Bacillus anthracis, exosporium, E. coli, gene regulation. reiterative transcription, transcription start site switching |
 |
TURNBOUGH |
CHARLES |
Structure/Function of the Bacillus anthracis Exosporium; Bacterial Gene Regulation |
anthrax, Bacillus anthracis, exosporium, E. coli, gene regulation. reiterative transcription, transcription start site switching |
 |
TURNBOUGH |
CHARLES |
Structure/Function of the Bacillus anthracis Exosporium; Bacterial Gene Regulation |
anthrax, Bacillus anthracis, exosporium, E. coli, gene regulation. reiterative transcription, transcription start site switching |
 |
TURNBOUGH |
CHARLES |
Structure/Function of the Bacillus anthracis Exosporium; Bacterial Gene Regulation |
anthrax, Bacillus anthracis, exosporium, E. coli, gene regulation. reiterative transcription, transcription start site switching |
 |
TURNBOUGH |
CHARLES |
Structure/Function of the Bacillus anthracis Exosporium; Bacterial Gene Regulation |
anthrax, Bacillus anthracis, exosporium, E. coli, gene regulation. reiterative transcription, transcription start site switching |
 |
TURNBOUGH |
CHARLES |
Structure/Function of the Bacillus anthracis Exosporium; Bacterial Gene Regulation |
anthrax, Bacillus anthracis, exosporium, E. coli, gene regulation. reiterative transcription, transcription start site switching |
 |
TURNBOUGH |
CHARLES |
Structure/Function of the Bacillus anthracis Exosporium; Bacterial Gene Regulation |
anthrax, Bacillus anthracis, exosporium, E. coli, gene regulation. reiterative transcription, transcription start site switching |
 |
TURNBOUGH |
CHARLES |
Structure/Function of the Bacillus anthracis Exosporium; Bacterial Gene Regulation |
anthrax, Bacillus anthracis, exosporium, E. coli, gene regulation. reiterative transcription, transcription start site switching |
 |
TURNBOUGH |
CHARLES |
Structure/Function of the Bacillus anthracis Exosporium; Bacterial Gene Regulation |
anthrax, Bacillus anthracis, exosporium, E. coli, gene regulation. reiterative transcription, transcription start site switching |
 |
UBOGU |
EROBOGHENE |
Vascular Biology of the Blood-Nerve Barrier; Molecular Biology and Physiology of Peripheral Neuroinflammation |
Blood-nerve barrier, chemokines, chronic inflammatory demyelinating polyradiculoneuropathy, Guillain-barre syndrome, in vitro models, in vivo animal models, neuroinflammation, peripheral neuropathy, vasculitis |
 |
UBOGU |
EROBOGHENE |
Vascular Biology of the Blood-Nerve Barrier; Molecular Biology and Physiology of Peripheral Neuroinflammation |
Blood-nerve barrier, chemokines, chronic inflammatory demyelinating polyradiculoneuropathy, Guillain-barre syndrome, in vitro models, in vivo animal models, neuroinflammation, peripheral neuropathy, vasculitis |
 |
UBOGU |
EROBOGHENE |
Vascular Biology of the Blood-Nerve Barrier; Molecular Biology and Physiology of Peripheral Neuroinflammation |
Blood-nerve barrier, chemokines, chronic inflammatory demyelinating polyradiculoneuropathy, Guillain-barre syndrome, in vitro models, in vivo animal models, neuroinflammation, peripheral neuropathy, vasculitis |
 |
UBOGU |
EROBOGHENE |
Vascular Biology of the Blood-Nerve Barrier; Molecular Biology and Physiology of Peripheral Neuroinflammation |
Blood-nerve barrier, chemokines, chronic inflammatory demyelinating polyradiculoneuropathy, Guillain-barre syndrome, in vitro models, in vivo animal models, neuroinflammation, peripheral neuropathy, vasculitis |
 |
UBOGU |
EROBOGHENE |
Vascular Biology of the Blood-Nerve Barrier; Molecular Biology and Physiology of Peripheral Neuroinflammation |
Blood-nerve barrier, chemokines, chronic inflammatory demyelinating polyradiculoneuropathy, Guillain-barre syndrome, in vitro models, in vivo animal models, neuroinflammation, peripheral neuropathy, vasculitis |
 |
UBOGU |
EROBOGHENE |
Vascular Biology of the Blood-Nerve Barrier; Molecular Biology and Physiology of Peripheral Neuroinflammation |
Blood-nerve barrier, chemokines, chronic inflammatory demyelinating polyradiculoneuropathy, Guillain-barre syndrome, in vitro models, in vivo animal models, neuroinflammation, peripheral neuropathy, vasculitis |
 |
UNLAP |
M. |
Drug Discovery in Cancer, Cystic Fibrosis, Tuberculosis, Parkinson's Disease and Oxidative Stress In Hypertension |
drug discovery, oxidative stress, cancer, parkinson's disease, hypertension, exchanger, molecular beacon, latent tb |
 |
UNLAP |
M. |
Drug Discovery in Cancer, Cystic Fibrosis, Tuberculosis, Parkinson's Disease and Oxidative Stress In Hypertension |
drug discovery, oxidative stress, cancer, parkinson's disease, hypertension, exchanger, molecular beacon, latent tb |
 |
UNLAP |
M. |
Drug Discovery in Cancer, Cystic Fibrosis, Tuberculosis, Parkinson's Disease and Oxidative Stress In Hypertension |
drug discovery, oxidative stress, cancer, parkinson's disease, hypertension, exchanger, molecular beacon, latent tb |
 |
UNLAP |
M. |
Drug Discovery in Cancer, Cystic Fibrosis, Tuberculosis, Parkinson's Disease and Oxidative Stress In Hypertension |
drug discovery, oxidative stress, cancer, parkinson's disease, hypertension, exchanger, molecular beacon, latent tb |
 |
UNLAP |
M. |
Drug Discovery in Cancer, Cystic Fibrosis, Tuberculosis, Parkinson's Disease and Oxidative Stress In Hypertension |
drug discovery, oxidative stress, cancer, parkinson's disease, hypertension, exchanger, molecular beacon, latent tb |
 |
UNLAP |
M. |
Drug Discovery in Cancer, Cystic Fibrosis, Tuberculosis, Parkinson's Disease and Oxidative Stress In Hypertension |
drug discovery, oxidative stress, cancer, parkinson's disease, hypertension, exchanger, molecular beacon, latent tb |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VAN WAARDENBURG |
ROBERT |
Structure-Function analysis of Tyrosyl-DNA phosphodieasterase I; Developing a DNA Repair Enzyme as Therapeutic Target for Anti-Cancer Treatment |
Structure-function analysis, Mechanism of Action of proteins and drugs (chemotherapeutics), Drug Development for novel therapeutic targets, Post-translational modification by Ubiquitin and SUMO (Small Ubiqitin like modifier), Protein interactions |
 |
VASSYLYEV |
DMITRY |
Structural studies of prokaryotic transcription |
|
 |
VASSYLYEV |
DMITRY |
Structural studies of prokaryotic transcription |
|
 |
VASSYLYEV |
DMITRY |
Structural studies of prokaryotic transcription |
|
 |
VASSYLYEV |
DMITRY |
Structural studies of prokaryotic transcription |
|
 |
VASSYLYEV |
DMITRY |
Structural studies of prokaryotic transcription |
|
 |
VASSYLYEV |
DMITRY |
Structural studies of prokaryotic transcription |
|
 |
VELU |
SADANANDAN |
|
|
 |
VELU |
SADANANDAN |
|
|
 |
VER HOEF |
LAWRENCE |
|
|
 |
VER HOEF |
LAWRENCE |
|
|
 |
VER HOEF |
LAWRENCE |
|
|
 |
VERMA |
SURESH |
Novel Pathways for Cardiac Fibrosis, Epitranscriptomic modification of mRNA in cardiac heart, Metabolic Regulation of Cardiac Cell death, Gut-Heart axis in heart failure |
Myocardial inflammation, Cardiac fibrosis, miRNAs, Extracellular vesicle, Cell signaling, mRNA epigenetic, Gut dysbiosis, and Hypertrophic heart failure. |
 |
VERMA |
SURESH |
Novel Pathways for Cardiac Fibrosis, Epitranscriptomic modification of mRNA in cardiac heart, Metabolic Regulation of Cardiac Cell death, Gut-Heart axis in heart failure |
Myocardial inflammation, Cardiac fibrosis, miRNAs, Extracellular vesicle, Cell signaling, mRNA epigenetic, Gut dysbiosis, and Hypertrophic heart failure. |
 |
VERMA |
SURESH |
Novel Pathways for Cardiac Fibrosis, Epitranscriptomic modification of mRNA in cardiac heart, Metabolic Regulation of Cardiac Cell death, Gut-Heart axis in heart failure |
Myocardial inflammation, Cardiac fibrosis, miRNAs, Extracellular vesicle, Cell signaling, mRNA epigenetic, Gut dysbiosis, and Hypertrophic heart failure. |
 |
VERMA |
SURESH |
Novel Pathways for Cardiac Fibrosis, Epitranscriptomic modification of mRNA in cardiac heart, Metabolic Regulation of Cardiac Cell death, Gut-Heart axis in heart failure |
Myocardial inflammation, Cardiac fibrosis, miRNAs, Extracellular vesicle, Cell signaling, mRNA epigenetic, Gut dysbiosis, and Hypertrophic heart failure. |
 |
VERMA |
SURESH |
Novel Pathways for Cardiac Fibrosis, Epitranscriptomic modification of mRNA in cardiac heart, Metabolic Regulation of Cardiac Cell death, Gut-Heart axis in heart failure |
Myocardial inflammation, Cardiac fibrosis, miRNAs, Extracellular vesicle, Cell signaling, mRNA epigenetic, Gut dysbiosis, and Hypertrophic heart failure. |
 |
VERMA |
SURESH |
Novel Pathways for Cardiac Fibrosis, Epitranscriptomic modification of mRNA in cardiac heart, Metabolic Regulation of Cardiac Cell death, Gut-Heart axis in heart failure |
Myocardial inflammation, Cardiac fibrosis, miRNAs, Extracellular vesicle, Cell signaling, mRNA epigenetic, Gut dysbiosis, and Hypertrophic heart failure. |
 |
VICE |
JASON |
|
vision, neuroplasticity, rehabilitation, aging, fMRI |
 |
WADICHE |
JACQUES |
Cellular and molecular basis of synaptic transmission and neuronal organization of microcircuits |
glutamate transport, synaptic transmission, cerebellum |
 |
WADICHE |
JACQUES |
Cellular and molecular basis of synaptic transmission and neuronal organization of microcircuits |
glutamate transport, synaptic transmission, cerebellum |
 |
WADICHE |
JACQUES |
Cellular and molecular basis of synaptic transmission and neuronal organization of microcircuits |
glutamate transport, synaptic transmission, cerebellum |
 |
WADICHE |
JACQUES |
Cellular and molecular basis of synaptic transmission and neuronal organization of microcircuits |
glutamate transport, synaptic transmission, cerebellum |
 |
WADICHE |
JACQUES |
Cellular and molecular basis of synaptic transmission and neuronal organization of microcircuits |
glutamate transport, synaptic transmission, cerebellum |
 |
WADICHE |
JACQUES |
Cellular and molecular basis of synaptic transmission and neuronal organization of microcircuits |
glutamate transport, synaptic transmission, cerebellum |
 |
WADICHE |
JACQUES |
Cellular and molecular basis of synaptic transmission and neuronal organization of microcircuits |
glutamate transport, synaptic transmission, cerebellum |